Prospera Financial Services Inc Seagen Inc. Transaction History

Prospera Financial Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $1.16 Million - $1.31 Million	-6,043 Reduced 67.45%	2,916 $618,000
Q2 2023 Aug 08, 2023	BUY	$187.64 - $206.25 $1.68 Million - $1.85 Million	8,959 New	8,959 $1.72 Million
Q3 2022 Oct 27, 2022	BUY	$135.27 - $180.11 $1.5 Million - $2 Million	11,113 New	11,113 $1.52 Million
Q2 2022 Aug 08, 2022	SELL	$108.81 - $179.33 $3,481 - $5,738	-32 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$119.61 - $157.85 $3,827 - $5,051	32 New	32 $5,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.